secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0000950170-23-017164
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences updates principal executive offices to two locations effective April 28, 2023
--------------------------------------------------------------------------------

- Effective April 28, 2023, Achieve Life Sciences established principal executive offices at 1040 West Georgia, Suite 1030, Vancouver, BC, Canada V6E 4H1.
- Also effective April 28, 2023, the Company's principal executive offices include 22722 29th Drive SE, Suite 100, Bothell, WA 98021.
- The address change was disclosed under Item 7.01 Regulation FD Disclosure in an 8-K filed May 3, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000095017023017164/0000950170-23-017164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000095017023017164/achv-20230428.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-017164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer